Berlin – Schnittker Möllmann Partners (SMP) advised Berlin-based medtech company Amboss on its Series B financing round with a total volume of EUR 30 million. The round was co-led by U.S. investor Partech and Russian VC company Target Global. Participants also included the current investors from the previous round, inter alia Cherry Ventures, Wellington Partners and Holtzbrinck Digital. The company says it is planning to use the fresh capital for the worldwide rollout of its online platform. In addition, it is envisaged for the fresh funds to be invested into further developing the intelligent advisory app that provides doctors with permanent access to precise and topical medical expertise in order to ensure best possible patient care. Amboss received compre-hensive legal advice by a team led by SMP partners Peter Möllmann and Martin Schaper.